Tier 2 Professors

undefined

PENG Chenghong

Email: chhpeng@188.com

Tel: 021-

Research Interests: Basic and clinical research of pancreatic tumor,robotic    assisted minimally invasive surgery

Biography

  • Chief Physician, Professor, PHD tutor, Fellow, American college of surgeons, visiting scholar at the university of Pittsburgh Organ Transplant Center. As a pioneer in the hepatobiliopancreatic field, he participated in the first split liver transplantation of China in 2002 and the first multiple organ transplantation of Asia in 2004.Besides, he is also committed to laparoscopic surgery and Robotic surgery. He has achieved more than 2000 robotic assisted hepatobiliary and pancreatic surgery, which keeps leading position in China.

  • He is member of Chinese Medical Association Pancreatic surgery branch, member of organ transplantation society of Chinese Medical Association, chairman of  Asian Clinical Robotic Surgery Association, Executive member of Clinical Robotic Surgery Association, Deputy Director of Shanghai Institute of Digestive Surgery, Fellow of American College of Surgeon;

  • Director of the Chinese Society of Pancreatic Diseases, former chairman of Chinese Anti-Cancer Association Professional Committee of Biliary Tract Cancer Society, former chairman of Shanghai Medical Association General Surgery branch.

Publications

  1. Li H, Wang X, Wen C, Huo Z, Wang W, Zhan Q, et al. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer. Mol Cancer. 2017;16(1):017-0738.

  2. Qin K, Wu Z, Jin J, Shen B, Peng C. Internal Hernia Following Robotic Assisted Pancreaticoduodenectomy. Med Sci Monit. 2018;24:2287-93.

  3. Zhou Y, Wang W, Shi Y, Lu X, Zhan Q, Chen H, et al. Substantial atherosclerotic celiac axis stenosis is a new risk factor for biliary fistula after pancreaticoduodenectomy. Int J Surg. 2018;49:62-7.

  4. Guan R, Chen Y, Yang K, Ma D, Gong X, Shen B, et al. Clinical efficacy of robot-assisted versus laparoscopic liver resection: a meta analysis. Asian J Surg. 2019;42(1):19-31.

  5. Feng Z, Shi M, Li K, Ma Y, Jiang L, Chen H, et al. Development and validation of a cancer stem cell-related signature for prognostic prediction in pancreatic ductal adenocarcinoma. J Transl Med. 2020;18(1):020-02527.

  6. Gu J, Xu Z, Ma Y, Chen H, Wang D, Deng X, et al. Surgical resection of metastatic pancreatic cancer: is it worth it?-a 15-year experience at a single Chinese center. J Gastrointest Oncol. 2020;11(2):319-28.

  7. Jin JB, Qin K, Yang Y, Shi YS, Wu ZC, Deng XX, et al. Robotic pancreatectomy for solid pseudopapillary tumors in the pancreatic head: A propensity score-matched comparison and analysis from a single center. Asian J Surg. 2020;43(1):354-61.

  8. Shi Y, Jin J, Huo Z, Wang J, Weng Y, Zhao S, et al. An 8-year single-center study: 170 cases of middle pancreatectomy, including 110 cases of robot-assisted middle pancreatectomy. Surgery. 2020;167(2):436-41.

  9. Shi Y, Jin J, Qiu W, Weng Y, Wang J, Zhao S, et al. Short-term Outcomes After Robot-Assisted vs Open Pancreaticoduodenectomy After the Learning Curve. JAMA Surg. 2020;155(5):389-94.

  10. Shi Y, Wang Y, Wang J, Ma Y, Huo Z, Jin J, et al. Learning curve of robot-assisted middle pancreatectomy (RMP): experience of the first 100 cases from a high-volume pancreatic center in China. Surg Endosc. 2020;34(8):3513-20.

  11. Jin J, Shi Y, Chen M, Qian J, Qin K, Wang Z, et al. Robotic versus Open Pancreatoduodenectomy for Pancreatic and Periampullary Tumors (PORTAL): a study protocol for a multicenter phase III non-inferiority randomized controlled trial. Trials. 2021;22(1):021-05939.

  12. Lin J, Zhai S, Zou S, Xu Z, Zhang J, Jiang L, et al. Positive feedback between lncRNA FLVCR1-AS1 and KLF10 may inhibit pancreatic cancer progression via the PTEN/AKT pathway. J Exp Clin Cancer Res. 2021;40(1):021-02097.

  13. Shi Y, Wang Q, Shi Z, Xie J, Jin J, Chen H, et al. Comparison between robot-assisted middle pancreatectomy and robot-assisted distal pancreatectomy for benign or low-grade malignant tumours located in the neck of the pancreas: A propensity score matched study. Int J Med Robot. 2021;17(3):9.

  14. Shi Y, Wang W, Qiu W, Zhao S, Wang J, Weng Y, et al. Learning Curve From 450 Cases of Robot-Assisted Pancreaticoduocectomy in a High-Volume Pancreatic Center: Optimization of Operative Procedure and a Retrospective Study. Ann Surg. 2021;274(6):e1277-e83.

  15. Weng Y, Jiang Y, Fu N, Jin J, Shi Y, Huo Z, et al. Oncological outcomes of robotic-assisted versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score-matched analysis. Surg Endosc. 2021;35(7):3437-48.

  16. Weng Y, Jin J, Huo Z, Shi Y, Jiang Y, Deng X, et al. Robotic-assisted versus open distal pancreatectomy for benign and low-grade malignant pancreatic tumors: a propensity score-matched study. Surg Endosc. 2021;35(5):2255-64.

  17. Feng Z, Li K, Qin K, Liang J, Shi M, Ma Y, et al. The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA. J Hematol Oncol. 2022;15(1):022-01338.

  18. Jin J, Yin SM, Weng Y, Chen M, Shi Y, Ying X, et al. Robotic versus open pancreaticoduodenectomy with vascular resection for pancreatic ductal adenocarcinoma: surgical and oncological outcomes from pilot experience. Langenbecks Arch Surg. 2022;407(4):1489-97.

  19. Shen Z, Chen H, Wang W, Xu W, Zhou Y, Weng Y, et al. Machine learning algorithms as early diagnostic tools for pancreatic fistula following pancreaticoduodenectomy and guide drain removal: A retrospective cohort study. Int J Surg. 2022;102(106638):29.

  20. Weng Y, Shen Z, Gemenetzis G, Jin J, Chen H, Deng X, et al. Oncological outcomes of robotic pancreatectomy in patients with pancreatic cancer who receive adjuvant chemotherapy: A propensity score-matched retrospective cohort study. Int J Surg. 2022;104(106801):5.